26/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

26/04/2024

Apr 26, 2024, 12:41 | Blog
Dickson Daniel: Young people getting involved in cancer Awareness is super important
Dickson Daniel, Team Lead at Onco Intelligence, shared on LinkedIn: "Young people getting involved in cancer…
Apr 26, 2024, 12:30 | Blog
Anas Elgenidy: Arsenic's shadowy influence - a systematic review of its carcinogenic role in gallbladder cancer
Anas Elgenidy, Medical Researcher at Lab of Proffesor Hurlemann, Oldenburg University, shared on LinkedIn: "Now, you…
Apr 26, 2024, 12:20 | Blog
World Immunization Week - Union for International Cancer Control
Union for International Cancer Control (UICC) shared on LinkedIn: "Cervical cancer is the fourth most common…
Apr 26, 2024, 12:05 | Blog
The final day of GIORNATE AIEOP 2024!
AIEOP: Italian Association of Pediatric Hematology and Oncology shared on LinkedIn: "That concludes the final…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 11:57 | Blog
Myriam Chalabi: What happens in Zurich….goes to ESMO25
Myriam Chalabi shared on X/Twitter: ''What happens in Zurich….goes to ESMO25! Fantastic meeting and discussions…
Apr 26, 2024, 11:43 | Blog
Timon Vandamme: 20.04.2024 is all about neuroendocrine cancer at ENDIMET2024
Timon Vandamme, Senior Clinical Investigator at Research Foundation – Flanders (FWO) and Independent Academic Staff…
Apr 26, 2024, 11:17 | Insight
Satya Prakash Yadav: Europe in 2022 BMT and Cell Therapy trends
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared on…
Apr 26, 2024, 11:10 | Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 26, 2024, 11:05 | Blog
Paolo Tarantino: Wonderful experience to brainstorm about the agnostic potential of ADCs with Roberto Carmagnani Pestana
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared a post by Roberto Carmagnani Pestana,…
All: 73 Posts: 41 - 50